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Abstract. A  novel 5S RNA-protein (RNP) complex in 
human and mouse cells has been analyzed using pa- 
tient autoantibodies.  The RNP is small (,,~7S) and 
contains most of the nonribosome-associated 5S RNA 
molecules in HeLa cells. The 5S RNA in the particle 
is matured at its 3' end, consistent with the results of 
in vivo pulse-chase experiments which indicate that 
this RNP represents a later step in 5S biogenesis than 
a previously described 5S*/La protein complex. The 
protein moiety of the 5S RNP has been identified as 
ribosomal protein L5,  which is known to be released 
from ribosomes in a complex with 5S after various 
treatments of the 60S subunit.  Indirect immunofluores- 
cence indicates that the L5/5S complex is concentrated 
in the nucleolus.  L5 may therefore play a role in de- 
livering 5S rRNA to the nucleolus for assembly into 
ribosomes. 
T 
HE biosynthesis  of ribosomes in mammalian  cells in- 
volves the assembly of rRNAs synthesized  by RNA 
polymerase I (18S, 28S, 5.8S) and by RNA polymerase 
III (5S) together with proteins  translated  from mRNAs syn- 
thesized by RNA polymerase II. Not only must the appear- 
ance of these components be coordinated on the transcrip- 
tional  level,  but  those  that  are  not  synthesized  in  the 
nucleolus (5S  and ribosomal proteins)  must become spe- 
cifically concentrated  there.  In higher eukaryotes the genes 
for 5S rRNA exist in tandemly repeating units which are not 
closely linked to the large blocks of rDNA that comprise the 
nucleolus  organizer  regions  (25).  5S rRNA must therefore 
travel from the nucleoplasm to its nucleolar site of assembly 
into ribosomes. 
In 1967, Knight and Darnell (16) discovered that only about 
half of the 5S rRNA molecules in mammalian  cells are as- 
sociated with 60S ribosomes. The remainder sediment in a 
range that could represent either free 5S RNA or 5S bound 
by one or a few protein molecules.  One mammalian  protein 
that is known to bind 5S RNA is the 50-kD La antigen. The 
La-bound 5S represents only a very small fraction ('M%) of 
the total and is slightly  elongated  at its 3' end (called  5S*) 
(38). Another well-characterized  5S-binding protein is tran- 
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scription  factor TF IIIA (10, 33). In the Xenopus oocyte, 5S 
RNA is stored for later assembly into ribosomes as a 7S RNP 
(37) containing  TF IIIA; TF IIIA is not present in a larger 
(42S)  oocyte particle  that  contains  several  other proteins 
and tRNAs as well as 5S RNA (15, 28, 36). Mammalian  TF 
IIIA has not yet been identified.  A third known 5S-binding 
protein is ribosomal protein L5 (34 kD) (6).  5S RNA/L5 
complexes are released from 60S ribosomes by EI~A (2, 19, 
42) or a variety of other treatments  (27, 34), and the isolated 
L5/5S particle  exchanges  5S  rRNA  specifically  (13, 32). 
However, it has not been determined whether L5 initially as- 
sociates with 5S before or only upon ribosome assembly. 
Here we have used autoantibody  probes to characterize  a 
5S  RNP that  represents  a  substantial  fraction  of the non- 
ribosomal 5S rRNA in mammalian  cells.  The particle ap- 
pears  to  contain  a  single  protein  component,  which  is 
ribosomal protein L5. Its cellular location, its kinetics of ap- 
pearance, and previously reported data on protein L5 suggest 
that this RNP is a precursor to ribosome assembly in mam- 
malian  cells. 
Materials and Methods 
Cells: Cultures, Labeling, Extracts 
HeLa cells were derived from standard laboratory stocks. Friend erythro- 
leukemia cells were provided by A. Sartorelli, Yale University (New Haven, 
CT). Cells were maintained in RPM1  1640 medium supplemented with 5% 
bobby calf serum (Gibco, Grand Island, NY), 60 gg/ml penicillin, and 100 
~tg/ml streptomycin, in 5% CO2 at 37~  For labeling with 32p, 2  x  107 
cells were suspended in 100 ml phosphate-minus MEM supplemented with 
dialyzed calf serum (Gibco), [32P]ortbophosphoric  acid was added at ei- 
ther 20 ~Ci/ml or 100 gCi/ml, and the cells were grown for 16 h. For [35S] 
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minus MEM supplemented with dialyzed calf serum and grown for either 
3 or 14 h before harvesting. Extracts of labeled cells were prepared by soni- 
cation as described (22). The protocol for the pulse-chase experiment was 
exactly as described by Rinke and Steitz (38). 
Preparation and A nalysis of  RNAs 
Patient sera were the kind girls of Drs. J. Hardin and J. Craft (Yale Univer- 
sity) and of Dr.  I". Greco (Waterbury, CT). Mouse monoclonal anti-ribo- 
some antibody (Y28) (21) was from Dr. E. Lerner. Immunoprecipitation was 
performed using Pansorbin (Catbiochem-Behring Corporation, San Diego, 
CA) or Protein A-Sepharose (Pharmacia Fine Products, Piscataway, NJ). 
Because of the low titer of the anti-5SRNP~ serum, it was routinely used 
in 3-5  ￿  higher amounts than other sera; therefore, with this serum, 50 
lag carrier tRNA per 10 lal serum was added to reduce RNase degradation 
of the RNAs to be analyzed. The protocol used to treat sonicates with pro- 
teinase K before immunoprecipitation was as described by Rosa et al. (39). 
RNAs were precipitated with ethanol from the aqueous phase of phenol 
chloroform-isoamyl alcohol extracts of Pansorbin or Protein A-Sepharose 
pellets and were fractionated on 10% polyacrylamide gels in 7 M urea, 90 
mM Tris-borate (pH 8.0),  1 mM EDTA as described (22).  For fingerprint 
analysis of gel-purified RNAs, bands located by autoradiography were ex- 
cised, eluted by soaking overnight in 0.5 M NaAc, 2.5 mM EDTA plus 20 
lag carrier RNA from yeast, and collected by ethanol precipitation of the 
supernatant. T1  digests of gel purified RNAs were  fractionated by elec- 
trophoresis on Katex cellogel strips, at pH 3.5, followed by homochromatog- 
raphy on PEI Cel 300 (Brinkmann) according to Barrell (1). 
Gradient Fractionation of  Extracts 
A cell extract was layered over an 11 ml 15-30% sucrose gradient in 20 mM 
Tris (pH 7.5),  130 mM NaC1,  10 mM MgCI2 and centrifuged for  16 h at 
t8,000 rpm in an SW41 rotor at 4~  Fractions were collected by puncturing 
the tube with a needle and collecting drops. For the quantitative immunopre- 
cipitation experiment, a 5 ml 5-20% gradient was prepared, and the extract 
fractionated for 80 min at 47,000 rpm in an SW50 rotor at 4~  This gradient 
gave the same profile as the longer 15-30% gradient. Portions of gradient 
fractions were either immunoprecipitated or extracted directly with phenol- 
chloroform-isoamyl alcohol. RNAs from the immunoprecipitates and from 
total  extracts were  displayed on  10%  polyacrylamide gels as described 
above. 
lmmunofluorescence 
Indirect immunofluorescence was performed using either patient sera fol- 
lowed by FITC-conjugated goat anti-human-IgG (Miles Laboratories Inc., 
Naperville, IL) or mouse monoclonal anti-ribosome antibodies followed by 
FITC-conjugated rabbit anti-mouse-lgG (the last three the gift of Dr.  E. 
Lerner). Prepared HEp-2 cell substrate w~s purchased from Immunocon- 
cepts, Inc. (Sacramento, CA). The immunofluorescence  procedure was ex- 
actly as described (12). 
Preparation of  80S Ribosomes, 60S Subunits, 
and the 5S/L5 Complex 
The cytoplasmic fraction from a HeLa nuclear extract (8) was clarified at 
13,000 rpm for 30 min at 4~  in a Sorvall SS34 rotor.  5-6 ml portions of 
the supernatant were loaded over 2 ml 1.35 M sucrose on top of 2 ml 2 M 
sucrose, both in 50 mM Tris (pH 7.0), 25 mM KC1, and 5 mM MgCI2, and 
the 80S ribosomes were pelleted overnight at 4~  at 48K rpm in a 50Ti rotor. 
The  pellets  were  rinsed  gently  with  doubly  distilled  water  and  were 
resuspended on ice to a  final concentration of 400 A260~m/ml  in low salt 
TKM (50 mM Tris [pH 7.0], 500 mM KC1, 5 mM MgCI.~). 100-lal aliquots 
of 80S ribosomes were frozen and stored at  -80~ 
To prepare 60S ribosomal subunits (3), each 100-pA portion (40 A260,m) 
of 80S ribosomes was diluted to a  final concentration of 1,5 M  KCI and 
1 mM puromycin in a total volume of 0.5 ml. The ribosomes were incubated 
15 min at 0~  then 10 min at 37~  400 lal of high salt TKM (50 mM Tris 
[pH  7.0],  1 M  KC1,  5  mM MgCI2)  was then added and  1.0 ml of dis- 
sociated ribosomes was loaded onto each 36 ml 5-20% sucrose gradient in 
low salt TKM. Gradients were centrifuged at 4~  at 28K rpm for 5.1 h in 
an SW28 rotor. The 60S ribosomal fractions were collected using an Isco 
density gradient fractionator, diluted 1:2 in low salt TKM, and centrifuged 
at 4~  for 16 h at 40,000 rpm in a 50Ti rotor.  The 60S ribosomal pellets 
were either resuspended immediately or frozen and stored at -20~  for fu- 
ture use. 
5S/L5 complexes were released from purified 60S ribosomes essentially 
as described by Blobel (2). Each pellet of 60S ribosomes was resuspended 
gently on ice in 200 lal of doubly distilled water.  The ribosomes were then 
divided into 2  t00-lal aliquots containing 5  A2o:~m  each and either 50 I.tl 
H20 or 25 lal H20 plus 25 lal 0.2 M  EDTA x~as added. After incubation 
for  15  min  at  0~  samples were  loaded  onto 4.8  ml  5-20%  sucrose 
gradients in 0.01 M  Tris (pH 7-7.5), 0.01 M  KCI and were centrifuged at 
40,000 rpm for 2.5 h at 4~  in a SW50 rotor.  After determination of their 
A260nm, fractions were either immunoprecipitated immediately with Protein 
A-Sepharose-bound antibody or precipitated in 10% TCA for  1 h on ice, 
boiled in l￿  Laemmli sample buffer (17), and were subjected to electropho- 
resis on 12% polyacrylamide gels. Immunoprecipitated fractions and total 
controls were phenol extracted and assayed by dot blot. 
Dot Blots 
RNA samples in 10 X SSC (0.15 M NaC1, 0.015 M  Na citrate) were blotted 
onto 0.45 lam nitrocellulose using a Schleicher and Schuell minifold appara- 
tus. The filters were washed in 20￿  SSC, baked for 2  or more hours at 
80~  and prehybridized overnight at 42~  in prehybridization mix (50% 
formamide, 5 x  SSC, 5 x  Denhardts (26), 50 mM potassium phosphate (pH 
Z3) ) containing 2.5%  freshly boiled sonicated salmon sperm DNA. The 
filters were then hybridized overnight at 42~  in hybridization mix (50% 
formamide, 5 x  SSC, 1  x  Denhardts, 20 mM potassium phosphate [pH 7.3]) 
to  which  freshly  boiled  1%  sonicated  salmon sperm  DNA  and  nick- 
translated Xenopus  borealis 5S somatic DNA (king girl of E. Gottlieb, Yale 
University) was added. The filters were washed three times for 10 min in 
2￿  SSC, 0.1% SDS at room temperature and two times for 20 min at 42~ 
in 0.1x SSC, 0.1% SDS. The blot was wrapped in Saran Wrap (Dow Com- 
ing Corp.,  Midland, MI) and exposed to film at  -70~ 
Protein Analysis by Partial Proteolysis 
The L5 band from HeLa 60S ribosomes  and the immunoprecipitated protein 
from [35S]methionine-labeled HeLa cell extracts were compared by Cleve- 
land  mapping  (digestion  during  electrophoresis)  using Staphylococcus 
aureus V8 protease (7).  Cleavage products were observed by silver staining 
(29) or autoradiography, respectively. 
Results 
Mammalian 5S RNA Is Found in a Ribonucleoprotein 
Particle Reactive with Patient Autoantibodies 
Fig.  1 A shows HeLa cell 32p-labeled RNAs immunoprecip- 
itated by a previously described (11) patient serum designated 
anti-5SRNP~  after fractionation on a  10% polyacrylamide 
gel. A single band, which comigrates exactly with the major 
5S species of the total cellular RNA  (lane labeled "E"), is 
seen (lane extract P).  Two other patient  sera  (called anti- 
5SRNP2  and anti-5SRNP3)  with the same specificity were 
subsequently identified;  their immunoprecipitation patterns 
are shown in Fig.  1 B. 
To ask whether protein is required for precipitation  of 5S 
RNA by these antibodies, two types of experiments were per- 
formed. First, immunoprecipitations were attempted  using 
naked RNAs purified by phenol-extraction/ethanol precipita- 
tion from the HeLa cell extract.  Deproteinized 5S RNA did 
not react detectabty (Fig. 1A, lane RNA, P); the RNA profile 
of the  corresponding  supernatant  (lane  RNA,  S)  demon- 
strated that the lack of 5S precipitation  was not simply due 
to degradation  by RNases present in the serum. Second, the 
requirement  of protein for antigenicity was confirmed in ex- 
periments using proteinase K (39);  upon proteolysis of the 
cell extract, 5S precipitability disappeared (not shown) where- 
as control experiments showed that the treatment neither de- 
stroyed the RNA nor interfered with the ability of other auto- 
antibodies to recognize naked RNA antigens (11). Antigenic 
conservation  could be  demonstrated  in at  least  one other 
mammalian species;  the  anti-5SRNP~  serum also precipi- 
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ascites cells (not shown). 
The RNA Contained in the lmmunoreactive RNP 
is Mature 5S RNA 
To confirm that the immunoprecipitated RNA was 5S rather 
than some other comigrating species, it was subjected to T1 
RNase fingerprint analysis. Fig. 2  shows the fingerprint of 
the 5S band excised from a gel-fractionated immunoprecipi- 
tate, compared with 5S ribosomal RNA obtained using the 
same type of gel to separate RNAs isolated from gradient- 
purified HeLa cell  ribosomes.  The  pattern  is  exactly the 
same as that of ribosome-associated 5S RNA, including the 
mature 5' and 3' termini. This is in contrast to another 5S-like 
RNA called 5S*, previously identified in ribonucleoprotein 
complexes reactive with  anti-La autoantibodies  (38).  5S* 
molecules have additional uridylate residues at their 3' ends 
and  give a  series of easily  identifiable spots  that  migrate 
lower and to the left of the indicated 3' terminus in T1 RNase 
fingerprints. 
The 5S RNP  Is Small and Contains Most of the 
Nonribosomal 5S RNA in the Cell 
From the results shown in Fig.  1, it was clear that the auto- 
antibodies  under  study  were distinct  from anti-ribosome 
antibodies (11, 21); anti-ribosome autoantibodies precipitate 
from 32p-labeled cell extracts equimolar amounts of 5S and 
5.8S rRNAs as well as the large rRNAs (which barely enter 
the gel). However, it was conceivable that the antigenic RNP 
might be generated by ribosome disassembly during prepa- 
ration  and  handling  of the  cell  extract;  for instance,  the 
5S/L5 complex can be released from ribosomes by various 
treatments (2,  19, 27, 34, 42). 
To test this possibility, we first asked from what region of 
a sucrose gradient the 5S RNP can be inmmnoprecipitated. 
In  the experiment shown in  Fig.  3,  we confirm the long- 
known fact (16) that only about half of the 5S RNA molecules 
in  HeLa cells are  ribosome associated;  in A,  where total 
RNAs are displayed, 5S RNA peaks both with 5.8S (in frac- 
tion 5) and again at the top of the gradient (fraction 10). Sur- 
prisingly, no immunoprecipitable 5S (B) is observed in the 
ribosome peak (fractions 5, 6). Rather, it appears exclusively 
at  the  top  of the  gradient  (in  fraction  10 and  11)  moving 
slightly slower than U1  RNA,  which is quantitatively con- 
rained in U1 snRNPs sedimenting at about 10S (23). C shows 
that the 5S at the top of the gradient is not nonspecifically 
precipitated by normal human serum. 
Figure 1.  Gel analysis of anti-5S  RNP immunoprecipitates. (A) 
Anti-5S  RNP~ serum was incubated with either sonicated 32p-la- 
beled HeLa cells (lanes extract)  or with deproteinized RNAs (lanes 
RNA) prepared from the sonicate. RNAs were recovered from Pan- 
sorbin immunoprecipitates (P) or supernatants (S) and fraction- 
ated on 10% polyacrylamide/7 M urea gels. 2~ indicates total RNAs 
in the cell sonicate; N indicates precipitation with normal human 
serum. Whereas RNAs from equal amounts of sonicate were ana- 
lyzed in the lanes P or N,  1/40 as much was used in the ,~ lane, 
1/45 as much in the lane extract S, and 1/10  as much in lane RNA 
S.  (B) 32P-labeled RNAs recovered from a Protein A-Sepharose 
immunoprecipitate using anti-5SRNP~ were compared with those 
of anti-Sin,  anti-5SRNP2, anti-5SRNP3 and a normal human se- 
rum (N) on a  10% polyacrylamide gel. 
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from an anti-5SRNP  immunoprecipitate (A) or from ribosomes 
(B) (the 60S-80S peak of a gradient as in Fig. 3) were digested to 
completion with T1 RNase and subjected to electrophoresis at pH 
3.5 followed by homochromatography as described by Barrell (1). 
The identity of all spots was confirmed by secondary digestion with 
RNase A. The positions of the blue (B) and yellow (Y) dyes and 
of the 5' end (pppGp) and 3' end (CUUUox) of mature 5S rRNA 
are indicated. 
To determine what fraction of the nonribosome-associated 
5S is contained in antigenic complexes, we ran freshly pre- 
pared  cell  extracts  in  small  sucrose  gradients  (which  re- 
quired minimal fractionation time). Immunoprecipitation of 
the top gradient fraction (D) revealed that over half of the 5S 
RNA could be immunoprecipitated when saturating amounts 
of antibody were used.  (Compare the supernatant (S) with 
the  immunoprecipitate (P)  for the  fraction comparable to 
fraction 11 in A-C.) By contrast, precipitation of another ali- 
quot of the same gradient fraction with saturating amounts 
of anti-La antibody (D) confirmed our previous conclusion 
(38) that only a very small amount (~,1-2 %) of the nonribo- 
some-bound 5S RNA is the 5S* precursor associated with 
the La antigen. 
Is the 5S RNP a Precursor to Ribosome-Associated  5S? 
To ask whether the antigenic 5S RNP might be an intermedi- 
ate in ribosome assembly, growing HeLa cells were exposed 
for 15 rain to 3H-uridine, followed by the addition of excess 
unlabeled uridine  and  cytidine.  Portions of cell  sonicates 
from various times up to 6 h were used for the preparation 
of total  RNA  and  for immunoprecipitation with  anti-La, 
anti-ribosome, and anti-5SRNP antibodies. The results are 
shown in Fig. 4. As the uridine label is chased out of anti-La 
precipitable 5S* precursor during the first hour (lanes 9-13), 
label accumulates in the RNA-protein complex recognized 
by anti-5SRNP antibodies (lanes 25-29).  Only after 4 h of 
chase does 5S RNA become detectable in ribosomes (lanes 
23-24). Meanwhile, the label in the anti-5SRNP-precipitated 
band declines (lanes 29-32).  Since the total label in the 5S 
region remains approximately constant over the time course 
of  the experiment (lanes 1-8), these observations are consis- 
tent with the following precursor product relationship:  La 
5S* ~  5S RNP ~  ribosomes. 
lmmunofluorescence Localization  of  the 5S RNP 
in the Nucleolus 
To determine the cellular location of the antigenic 5S RNP, 
indirect immunofluorescence studies were performed using 
monkey (Vero) cells and human (HEp-2) cells (Fig. 5). The 
pattern  obtained  with  anti-5SRNP,  (A)  shows  bright  nu- 
cleoli and some cytoplasmic staining relative to normal se- 
rum (C). It is therefore similar to that given by an anti-ribo- 
some monoclonal antibody (B; also see reference 21), except 
that the nucleoli are relatively brighter with anti-5SRNP. As 
a control, we show the nuclear, non-nucleolar location (D) 
observed for the Sm snRNPs (containing U1, U2, U4, U5, 
and U6 RNAs). Caution should always be exercised when in- 
terpreting immunofluorescence results since many autoim- 
mune  sera contain  mixtures of antibodies;  however, anti- 
5SRNP2  and  anti-5SRNP3  gave  similar  staining  patterns 
(not shown) to that in Fig.  5 A. 
The Protein Component of the 5S RNP is 
Ribosomal Protein L5 
To identify the protein(s) associated with 5S  RNA in the 
RNP,  we subjected  [35S]methionine-labeled HeLa cell ex- 
tracts to immunoprecipitation using the three anti-5SRNP 
sera available. As shown in Fig. 6, all precipitates included 
a  common protein band  of '~35  kD.  While anti-5SRNP~ 
and  anti-5SRNP2  showed  no  additional  bands  compared 
with  the  lane  containing  normal  human  serum  (N),  the 
strongest  serum,  anti-5SRNP3,  precipitated a  number  of 
other proteins, presumably because of second specificities. 
The 35-kD band comigrates with the 60S ribosomal subunit 
protein that has been identified as L5 (lane 60S) (6). 
Although the data shown in Fig.  6  made it seem highly 
likely that the protein component of  the 5S RNP is ribosomal 
protein L5, more rigorous identification was necessary. In 
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mass might also be expected for mammalian TF IliA, which 
has not yet been identified and characterized. Our first ap- 
proach was to use Western blots in the hope of  demonstrating 
anti-5SRNP reactivity with a protein component of purified 
60S ribosomal subunits. Unfortunately, after many trials, we 
were unable to obtain a positive signal with any of the three 
sera available. Lack of reactivity in Western blots is often a 
problem with patient autoantibodies (45), even those that ex- 
hibit extremely  high titers in recognizing their corresponding 
native autoantigens. 
We then asked whether it might be possible to immunopre- 
cipitate the well-studied 5S/L5 complex that is released from 
60S ribosomes. Fig. 7 confirms the early findings of Blobel 
(2) and shows that exposure to EDTA (bottom gel) releases 
5S rRNA nearly quantitatively (see dot blot) along with a 
single protein previously identified as L5 (42). Both migrate 
in the top three fractions of the gradient analyzed. When 
fractions from a gradient containing ElTl'A-treated 60S ri- 
bosomes were  subjected to  immunoprecipitation by anti- 
5SRNP2  versus normal serum (Fig.  8), 5S RNA was pre- 
cipitated by the autoantibody only from the top of the gradient 
(fractions 8-10) where the 5S/L5 complex sediments. This 
argues  strongly  that  the  protein  recognized by the  anti- 
5SRNP antibodies is L5. 
Finally, we compared the partial proteolysis profile of the 
3sS-labeled  immunoprecipitated protein with that of L5 ex- 
cised from an SDS gel fractionating purified 60S ribosomes. 
Fig. 9 shows that upon exposure to V8 protease, the labeled 
and unlabeled proteins yield similar patterns of  peptide prod- 
ucts; some differences are to be expected since the methio- 
nine content of the various silver-stained peptides will vary. 
By contrast, the 60S ribosomal protein migrating just above 
L5 (designated U) gives a distinctly different pattern. This 
further argues that the 5S RNP protein is L5 rather than an- 
other ribosomal or nonribosomal polypeptide. 
Discussion 
We  have  studied  a  novel  5S  RNA-containing  RNP  from 
Figure 3.  Sedimentation of the 5S RNP in a sucrose gradient. A 
32P-labeled HeLa cell sonicate was layered onto a 15-30% sucrose 
gradient and sedimented as described in Materials and Methods. 
Eleven fractions were collected and divided into  three portions with 
relative volumes of 1:10:10. (A) Total RNAs extracted from the 
small portion of each gradient fraction. (B) RNAs immunoprecipi- 
tated from one of the large portions using anti-5SRNPj  serum. ( C 
and D) (C) RNAs immunoprecipitated from the other large portion 
using normal human serum. The r  lanes display fractions of the 
original cell sonicate that were treated like the remaining samples 
in panels A, B, and C, respectively. Markers run in a parallel gra- 
dient indicated that fraction 5 corresponded to about 70S. (D) Two 
atiquots from the top fraction of a smaller gradient (see Materials 
and  Methods)  were  subjected  to  precipitation  with  saturating 
amounts (5 x  the usual ratio of serum to extract) of anti-5SRNP~ 
antibody or of anti-La antibody. P  = RNAs f\rom  the immunopre- 
cipitated pellets.  S  =  RNAs in the  supernatant  from the anti- 
5SRNP immunoprecipitation. The anti-La lane was run on another 
gel, but represents an equal amount of the same gradient fraction 
and was exposed for the same period of time as the anti-5SRNP 
gel  lanes. 5S* is a  3' extended precursor  to 5S  RNA which is 
bound by the antigenic La protein (38). 
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cell sonicates after pulse-chase labeling. 
HeLa ceils, labeled for 15 min with [5,6- 
3H]-uridine, were chased with unlabeled 
uridine and cytidine for various times (0, 
5,  10, 30, 60,  120, 240, 360 min). Total 
small  RNAs from each  time  point  are 
shown together with RNAs precipitated by 
anti-La antibody, by anti-ribosome  anti- 
body, and by anti-5SRNP~ antibody, af- 
ter fractionation on a 10% polyacrylamide 
gel. The relative amounts of cell sonicate 
used for total RNA (lanes 1-8) compared 
with anti-La (lanes 9-16), anti-ribosome 
(lanes 17-24) and anti-5SRNP  immuno- 
precipitation (lanes 25-32) were 1:5:25:5, 
but precipitation by the anti-ribosome an- 
tibody was far from quantitative in the ex- 
periment presented. 
mammalian cells that is recognized by rather rarely occur- 
ring autoantibodies.  The RNP  contains 5S  RNA that has 
been matured at its 3' end and comprises at least 50% of the 
nonribosome-associated 5S RNA in cell extracts. The RNP 
appears to contain a  single protein component, which has 
been identified as the 60S ribosomal protein L5. Pulse-chase 
studies and the nucleolar location of the 5S/L5 RNP suggest 
that this particle is a precursor to ribosomes in somatic mam- 
malian cells. 
The Protein in the 5S RNP is L5 
From the start, it seemed most likely that the protein compo- 
nent of the antigenic 5S RNP might be ribosomal protein L5. 
This is the protein that is bound tightly to released 5S when 
60S ribosomes are exposed to EDTA (2, 19, 42), formamide 
(34), or citrate (27). Also, HeLa cell L5 exhibits an unusually 
large free pool size (18, 35), making it a very attractive candi- 
date for interacting with 5S RNA before its incorporation 
into ribosomes. However, for two reasons, identification of 
this protein proved difficult. (a) We never succeeded in ob- 
taining a positive signal in Western blots with any of the three 
sera available. This could be due to a labile determinant or 
to a  requirement for the presence of RNA to maintain the 
reactive autoepitope. Lack of reactivity in blots has been ob- 
served with other RNP autoantigens (45).  (b) Mammalian 
L5  is  an  exceedingly insoluble  polypeptide (6,  13). This 
property  accounts  for  the  fact  that  L5  was  not  initially 
identified as a 5S binding protein (44, but see 30) and could 
explain recurrent problems we had "losing" the protein dur- 
ing analysis of the 5S RNE 
However, by subjecting the newly-released 5S/L5 complex 
directly to immunoprecipitation, we were able to demon- 
strate its reactivity with the antisera (Fig. 8). Because L5 is 
the only protein comigrating with 5S rRNA in gradients of 
EDTA-dissociated ribosomes (Fig. 7), we conclude that L5 
must be the antigenic protein. 
Since L5 is a ribosome component, it may seem curious 
that the anti-5SRNP antisera do not immunoprecipitate in- 
tact ribosomes from cell extracts or brightly stain the cyto- 
plasm in immunofluorescence studies.  However, 5S rRNA 
has been shown to be largely unavailable to the exterior once 
in place on the ribosome (24), making it likely that L5 is also 
buried. Some reexposure of the determinant upon cell fixa- 
tion might explain the slight cytoplasmic fluorescence that is 
observed (Fig.  5) with anti-5SRNP antibodies. 
A Pathway  for 5S Biogenesis in Mammalian Cells 
The identification of autoantibodies directed against three 
different ribonucleoprotein states of mammalian 5S RNA has 
provided a unique opportunity to order the corresponding 
steps in the lifetime of this RNA molecule. Previously, we 
demonstrated  (38)  that  newly  synthesized HeLa cell  5S* 
RNA,  the majority of which has one or two additional U 
residues at its 3' end, is transiently associated with the 50 kD 
La antigen, which binds its U-rich terminus (41). Here we 
have shown that once matured, the 5S RNA binds L5 to enter 
a second small RNP state, whose labeling profile in pulse- 
chase experiments (Fig. 4) suggests that it too is a precursor 
to ribosome-bound 5S. As previously observed (16, 20, 43), 
the assembly of 5S RNA into ribosomes (a large RNP state) 
in HeLa cells is very slow; even after 4 h of chase the 5S band 
contains less than 1/10  as much label as 5.8S (see Fig. 4, lanes 
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Steitz et al. Mammalian  5S/L5 RNP  551 Figure 5. Immunofluorescent  staining of HEp-2 human cells with autoantibodies.  (a) Anti-5SRNPt serum; (b) anti-ribosome monoclonal 
antibody; (c) normal human serum; (d) anti-Sin serum. Note that the exposure time in (c) is much longer than for the other antibodies, 
thereby exaggerating the background staining. 
The Journal of Cell Biology, Volume 106, 1988  552 Figure 6. Gel analysis of [35S]methionine-labeled  anti-5SRNP im- 
munoprecipitates. Antibodies preabsorbed to Protein A-Sepharose 
were incubated with 35S-labeled HeLa cell sonicates. The washed 
immunoprecipitates  were boiled in lx Laemmli gel sample buffer 
and fractionated on 10%  SDS gels. M indicates ~*C-labeled high 
MW protein markers (Amersham Corp., Arlington Heights, IL). 
Sm and Nindicate precipitation  with anti-Sm serum and normal hu- 
man serum, respectively. Proteins from purified 60S  ribosomal 
subunits were fractionated in an adjacent lane of the same gel and 
visualized by Coomassie staining. The L5 band was identified by 
comparison with the known pattern of 60S ribosomal proteins (6). 
23 and 24), and several more hours are required for the two 
RNAs to appear equimolar in anti-ribosome immunoprecip- 
itates (not shown). 
A three-step pathway, consistent with the above data can 
be proposed for mammalian 5S RNA assembly into ribo- 
somes: La 5S* RNP --" 5S/L5 RNP --" ribosomes. Because 
it was not possible to use saturating amounts of each type of 
antibody in our pulse-chase studies, we cannot claim that this 
pathway is the only pathway of 5S rRNA biogenesis. Like- 
wise, additional RNP intermediates may exist, and we do not 
know to what extent the various RNP states might overlap. 
It is even conceivable that 5S RNA complexed with L5 might 
be destined for degradation (20), but its nucleolar location 
makes this seem unlikely. 
Indirect immunofluorescence  studies using the same three 
autoantibodies have further suggested where the various in- 
termediates in 5S biogenesis might be localized in the mam- 
malian cell. Anti-La stains the nucleus most brightly, but the 
nucleoli and cytoplasm also  show some La antigen (12). 
Since there are numerous RNA polymerase III transcripts in 
the cell, all of  which bind the La protein at least initially (12), 
definitive conclusions concerning  the precise  location  of 
only one of these,  5S*,  cannot be made.  However,  since 
mammalian 5S genes are not associated with the rDNA at 
nucleolus organizer regions (25),  it seems most likely that 
newly synthesized 5S* RNA appears first in the nucleoplasm, 
bound by La. 
In contrast to anti-La, the anti-5S RNP antibody gives 
primarily nucleolar fluorescence. It is known that 5S assem- 
bles into ribosomes in the mammalian cell nucleolus (43). 
Either of the two following scenarios are therefore possible: 
(a) after (or during) its 3' end maturation 5S RNA makes a 
short excursion into the cytoplasm (where it picks up L5) be- 
fore entering the nucleolus, as first suggested by Leibowitz 
et al. (20);  or (b) newly synthesized 5S RNA binds L5 al- 
ready present in the nucleoplasm and quickly travels to the 
nucleolus where it assembles as a bimolecular complex into 
nascent ribosomes.  The observation that 5S  RNA synthe- 
sized  in  isolated nuclei  in vitro can be  chased from the 
anti-La precipitable to the anti-5S RNP precipitable form 
(Rinke, J., data not shown) is more consistent with the sec- 
ond possibility, for it strongly argues that the L5 protein must 
be present in isolated nuclei. 
The pathway proposed for 5S biogenesis in mammalian 
cells begins to resemble the multiple protein-bound states 
that have been elucidated for 5S RNA in another well-studied 
vertebrate system, the amphibian oocyte. A 7S particle con- 
taining 5S  RNA and transcription factor TF IliA (10, 33) 
serves as a storage particle in previtellogenic oocytes (37). 
Another 5S storage form, a 42S RNP, contains 2 different 
proteins, 5S and tRNA molecules (15, 28, 36). A third 5S RNP 
can be released from mature amphibian oocyte ribosomes by 
EDTA treatment (15). Also, a 55-kD protein which cross- 
reacts with human anti-La autoantibodies binds to newly 
synthesized 5S RNA made in Xenopus oocyte extracts (Gott- 
lieb, E., and H. Pelham, unpublished observations). The or- 
der of these various states and how they might relate to 5S 
biogenesis in Xenopus somatic cells are still unclear. 
Likewise in the yeast, S. cerevisiae. 5S rRNA is released 
from ribosomes complexed with a protein which is the yeast 
L5 equivalent, YL3 (31). Very recent studies by Brow and 
Geiduschek (5) have detected formation of a 5S/YL3 com- 
plex in an active yeast cell-free system programmed with a 
5S rRNA gene. Their data further indicate the existence of 
a TFIBA/5S complex, and suggest that binding of the two 
proteins to 5S is mutually exclusive.  Although the order of 
these states has not been determined, the yeast complex in- 
volving 5S and L5 strongly resembles that described here for 
HeLa (and presumably other mammalian somatic) cells. 
Is L5 a Nucleolar Targeting Protein? 
Previous studies have identified polypeptide sequences that 
target proteins to the nucleus (9). Whether analogous signals 
specify protein delivery to the nucleolus is not known. Alter- 
native explanations for subcellular localization suggest that 
the mechanism is  not an active process,  but that cellular 
components simply concentrate wherever specific binding 
sites exist. In the case of the 5S/L5 RNP, its high abundance 
(approximately equal to that of cytoplasmic ribosomes [10V 
cell] far greater than the number of assembling ribosomes) 
argues against the idea that this complex becomes concen- 
trated in the nucleolus simply because of its binding to na- 
scent ribosomes. 
If L5 is a nucleolar targeting protein, it may explain deliv- 
ery of another important small RNA molecule to the nucleo- 
lus. Viroids, which are important plant pathogens, replicate 
in plant cell nucleoli (40).  Within the highly conserved cen- 
tral domain of nearly all viroid RNAs (14) is a bulge-loop 
structure which exhibits primary sequence homology to eu- 
karyotic 5S rRNA. These regions are apparently also struc- 
Steitz et al. Mammalian 5S/L5 RNP  553 Figure  7.  Release of the  5S/L5 complex from 60S 
subunits by EDTA. 60S ribosomal subunits, in the ab- 
sence (top gel) or presence (bottom gel) of EDTA, 
were fractionated on 5-20%  sucrose gradients. An 
aliquot of each fraction (1-14) was blotted onto nitro- 
cellulose and  probed  with  nick-translated Xenopus 
borealis 5S somatic DNA (,~ 5S RNA). Gradient frac- 
tions were  then "lVAk precipitated and  analyzed on 
10% Laemmli gels along with 60S ribosomal subunits 
and low molecular weight protein markers (Pharma- 
cia Fine Chemicals) as in Fig. 6. 
Figure 8. Immunoprecipitation of gradient fractions containing EDTA-treated 60S ribosomes with anti-5SRNP2 or normal human serum. 
Small portions of each fraction from two 5-20% sucrose gradients, one containing untreated (-EDTA) and one containing EDTA-treated 
( + EDTA ) 60S ribosomes, were phenol extracted, blotted onto nitrocellulose, and probed with 32p-labeled 5S RNA (,~ 5S RNA). The re- 
mainder of each fraction from the gradient containing EDTA-treated 60S ribosomes and from a parallel identical gradient were immunopre- 
cipitated with anti-SSRNP2 or normal human serum. The immunoprecipitates were phenol-extracted and analyzed by dot blot as above 
(1~.). 
The Journal of Cell Biology,  Volume 106, 1988  554 Figure  9.  Comparison of the 35S-labeled  immunoprecipitated pro- 
tein with  60S  ribosomal proteins by  partial  proteolysis.  60S  ri- 
bosomal  subunits  and  a  1:1  mixture of an  equal  amount of 60S 
subunits  and  a  35S-labeled  immunoprecipitate were  fractionated 
on a  15%  Laemmli gel.  The L5 band was excised from the gel as 
was a second band running just above it ( U, lane 2). These proteins 
were then subjected to proteolysis with Staphylococcus aureus V8 
protease (I"8) during electrophoresis on a second 15% Laemmli gel. 
Lane 1 contains low molecular mass protein markers while lanes 
2  and 3  contain the excised proteins,  U and LS,  in the absence of 
V8 protease. In lanes 4 and 5, the upper protein (U), excised from 
pure 60S ribosomes, was digested with 0.1 gg or 0.2 txg of V8 pro- 
tease, respectively. Similarly, in lanes 6 and 7, L5 was treated with 
0.1  lag  or 0.2  gg  V8  protease.  The  resulting  partial  proteolysis 
profiles (lanes 1-7) were visualized by silver stain.  In lanes 8 and 
9, the L5 band excised from a mixture of purified  60S ribosomes 
(nonradioactive  L5)  and  35S-labeled  immunoprecipitate  (35S-la- 
beled LS) was digested with 0.05 ~tg or 0.025 I~g V8 protease. Lane 
10 contains the same mixture of asS-labeled  and nonradioactive L5 
in the absence of V8 protease. Patterns of proteolysis in lanes 8-10 
were visualized by automdiogmphy. 
turally homologous, since both 5S rRNAs and viroids form 
a high efficiency UV-crosslink within this sequence (4). In- 
triguingly, this sequence occurs within that portion of the 5S 
rRNA molecule that is protected from tt-sarcin by binding 
to ribosomal protein L5 (13). The possibility that L5 selec- 
tively binds to viroid RNAs and delivers them to the nucleo- 
lus is currently under investigation. 
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